EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comorbidity-adjusted life expectancy using comprehensive summary measures of medical history: nationwide, population-based study in Sweden

Marcus Westerberg, Hans Garmo, Jonas F Ludvigsson, Pär Stattin, Rolf Gedeborg

European Journal of Epidemiology · 20.08.2026

DOI: 10.1007/s10654-026-01453-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Epidemiology, online erschienen am 20.08.2026. Verfasst von Marcus Westerberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. marcus.westerberg@uu.se. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A multidimensional diagnosis-based comorbidity index (MDCI) and a drug comorbidity index (DCI) have demonstrated superior discrimination of mortality risk compared to the Charlson Comorbidity Index (CCI) in smaller specific populations. We aimed to evaluate performance of these indices in an entire population according to age, sex, and to estimate comorbidity-adjusted life expectancy (CALE), i.e. life expectancy conditional on age and comorbidity. Open cohort study of all adults residing in Sweden in 2006–2022. Discrimination of mortality risk at one year of follow-up was assessed through the C-index. CALE was estimated using parametric survival models based on age and comorbidity. 10 079 529 individuals were included. The MDCI (C-index 0.882 [95% CI 0.882–0.882]) and DCI (C-index 0.871 [95% CI 0.870–0.871]) improved discrimination of mortality risk compared to the CCI (C-index 0.811 [95% CI 0.811–0.812]). For each age above 40 the combination of MDCI and DCI clearly separated risk of death within levels of CCI and identified a wider range of CALE than CCI. At age 70 CALE based on the combination of MDCI and DCI varied from 7.0 to 17.9 years at the 5th and 95th percentile in men, and from 8.9 to 20.2 years in women. CALE based on CCI varied from 11.0 to 16.1 years in men and 11.7 to 18.4 years in women. Comprehensive comorbidity indices improved discrimination of mortality risk over the CCI in all age groups in men and women and identified a wider range of comorbidity-adjusted life expectancy in individuals of the same age.

Schlagwörter

Stichwörter der Autor:innen

ComorbidityDiscriminationLife expectancyMultimorbiditySurvival

Autor:innen und Institutionen

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. marcus.westerberg@uu.se.
  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Paediatrics, Örebro University Hospital, Örebro, Sweden.
  • Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Förderung

  • Uppsala University

Zitieren

APA

Westerberg, M., Garmo, H., Ludvigsson, J. F., Stattin, P., & Gedeborg, R. (2026). Comorbidity-adjusted life expectancy using comprehensive summary measures of medical history: nationwide, population-based study in Sweden. European Journal of Epidemiology. https://doi.org/10.1007/s10654-026-01453-8

Vancouver

Westerberg M, Garmo H, Ludvigsson JF, Stattin P, Gedeborg R. Comorbidity-adjusted life expectancy using comprehensive summary measures of medical history: nationwide, population-based study in Sweden. European Journal of Epidemiology. 2026. doi:10.1007/s10654-026-01453-8

BibTeX
@article{Westerberg2026,
  author = {Westerberg, Marcus and Garmo, Hans and Ludvigsson, Jonas F and Stattin, Pär and Gedeborg, Rolf},
  title = {Comorbidity-adjusted life expectancy using comprehensive summary measures of medical history: nationwide, population-based study in Sweden},
  journal = {European Journal of Epidemiology},
  year = {2026},
  doi = {10.1007/s10654-026-01453-8}
}
Kostenlos starten →